Median Diagnostics Inc
233250
Company Profile
Business description
Median Diagnostics Inc is a Korea based company engaged in the human and animal disease diagnosis business, which falls within the in vitro diagnostics industry. In vitro diagnostic kits are defined as medical devices, reagents, calibrators, specimen containers, and other items that provide information for diagnosing, monitoring, or assessing the suitability of patients or animals by testing specimens such as tissue, blood, or urine in vitro.
Contact
878 Sunhwan-daero
Dongnae-myeon
Gangwon-do
Chuncheon-si200-883
KORT: +82 332440100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
67
Stocks News & Analysis
stocks
Navigating the ASX dividend landscape in 2026
Dividend yields are well below the 10-year average. Here’s how to navigate lower yields in 2026.
stocks
Meta stock has struggled amid AI spending concerns. Is it a buy?
Meta stock has lost ground as investors raise concern over capital expenditures and risky AI strategies.
stocks
Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth
We think Netflix stock is moderately overvalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,174.70 | 14.60 | 0.16% |
| CAC 40 | 8,069.17 | 6.59 | 0.08% |
| DAX 40 | 24,560.98 | 142.14 | -0.58% |
| Dow JONES (US) | 49,077.23 | 588.64 | 1.21% |
| FTSE 100 | 10,138.09 | 11.31 | 0.11% |
| HKSE | 26,575.18 | 9.88 | -0.04% |
| NASDAQ | 23,224.82 | 270.50 | 1.18% |
| Nikkei 225 | 53,865.13 | 1,090.49 | 2.07% |
| NZX 50 Index | 13,556.87 | 139.70 | 1.04% |
| S&P 500 | 6,875.62 | 78.76 | 1.16% |
| S&P/ASX 200 | 8,851.70 | 15.80 | 0.18% |
| SSE Composite Index | 4,114.92 | 2.02 | -0.05% |